Optimization of treatment of recurrent vulvovaginal candidiasis
نویسندگان
چکیده
منابع مشابه
Evidence-Based Management of Recurrent Vulvovaginal Candidiasis
Vulvo-vaginal candidiasis (VVC) is a common infection among women. 5-8% of women with acute infection experience recurrent vulvo-vaginal candidiasis (RVVC). There is currently no gold standard treatment for RVVC. Although antifungal agents such as imidazoles have been successfully used as first-line treatment for acute VVC, the effectiveness of these medications is limited for RVVC, and various...
متن کاملTreatment Considerations in Vulvovaginal Candidiasis
In 1990, more than 13 million American women received prescriptions for treating vaginitis-the most common reason for visiting the gynecologist. (1) Vaginitis caused by yeast species accounts for approximately 40% of these cases, second only to bacterial vaginosis (45%). (2,3) The incidence of vulvovaginal candidiasis (VVC) has increased dramatically in the past decade. In the United Kingdom, t...
متن کاملProbiotics in the treatment of vulvovaginal candidiasis
Probiotics in the treatment of vulvovaginal candidiasis as hydrogen peroxide1, 2,4,5,6. A number of factors are thought to disturb the balance of vaginal micro-flora, including repeated antibiotic use, hormonal imbalances, chronic stress and a processed diet7, 9. Opportunistic pathogens, such as the yeast Candida, may take advantage of this change in the vaginal environment. Although Candida is...
متن کاملProbiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Vulvovaginal candidiasis (VVC) is a common infection affecting the quality of life of many women. Probiotics have been investigated as possible agents for the prevention of recurrences of VVC. We reviewed the available literature. In some studies the development of VVC was associated with either a low number of lactobacilli in the vagina or with the presence of H2O2-non-producing vaginal lactob...
متن کاملThe Recurrent Vulvovaginal Candidiasis: Proposal of a Personalized Therapeutic Protocol
Background. Recurrent vulvovaginal candidiasis (RVC) is an increasing challenge in clinical practice. Objective. The purpose of this study was to reduce the episodes of RVC through the intake of fluconazole 200 mg/dose with a personalized regimen at growing administration intervals with a probiotic. Method. 55 patients received a 200 mg fluconazole as an induction dose for 3 alternate days. Sym...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical alphabet
سال: 2019
ISSN: 2078-5631
DOI: 10.33667/2078-5631-2019-2-14(389)-27-30